TMFGreenwave

Article

TMFGreenwave published an article 7:52 PM

Another Multiple Sclerosis Winner for Biogen

Biogen submits Plegridy for FDA approval.

Article

TMFGreenwave published an article 6:57 PM

1 Big Pharma Phase 3 Failure

Pfizer's non-Hodgkin's lymphoma drug saw its phase 3 trial halted for lack of efficacy.

Article

TMFGreenwave published an article 6:27 PM

When Savvy Dealmaking Borders on Reckless Spending

Is Elan deftly making deals or blowing its newfound cash hoard?

Article

TMFGreenwave published an article 8:10 PM

FDA Green Light = Surprise Share Surge

Did this FDA decision really justify a big stock pop?

Article

TMFGreenwave published an article 6:06 PM

Everyone Wins From This Acquisition

Actavis buys Warner Chilcott rather than get acquired itself and investors win.

Article

TMFGreenwave published an article 2:00 PM

Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started

Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.

Article

TMFGreenwave published an article 1:00 PM

The Implications of Monsanto's Supreme Court Win

The biotech agricultural giant racks up yet another patent triumph.

Article

TMFGreenwave published an article 11:52 AM

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Article

TMFGreenwave published an article 7:32 PM

Cancer Drug Drama Rocks 2 Biotech Stocks

ASCO abstracts lead to one big pop and one big drop

Article

TMFGreenwave published an article 7:13 PM

Presentation Pandemonium = 30% Pop

Why shares of Aegerion soared more than 30% today.

Article

TMFGreenwave published an article 6:03 PM

FDA Prioritizes New Hepatitis C Drug

Is Johnson & Johnson's simeprevir destined to be the first next-gen hepatitis-C drug.

Article

TMFGreenwave published an article 5:57 PM

The Danger of Chasing This IPO's Profits

The largest contract research organization is back on the market

Article

TMFGreenwave published an article 6:00 PM

Curing Back Pain and Preventing Diabetes

Two EU studies have some really interesting studies with far-reaching impacts.

Article

TMFGreenwave published an article 6:00 PM

Do Micro-Cracks Equal Major Problems?

Intuitive Surgical warns of a potentially defective module.

Article

TMFGreenwave published an article 5:33 PM

The Real Impact of Irrational Hospital Pricing

The CMS releases hospital pricing data for the first time, and outrage ensues.

Article

TMFGreenwave published an article 4:10 PM

How the Patent Cliff Is Shrinking U.S. Spending

Is the patent cliff a government spending cure?

Article

TMFGreenwave published an article 3:51 PM

No Relief in Sight for Pain Therapeutics Investors

Why shares of Pain Therapeutics were slashed in half.

Article

TMFGreenwave published an article 2:41 PM

1 Biotech's Surprise Dilution Decoded

Isis Pharmaceuticals gives biotech investors a painful reminder that dilution can come when they least expect it.

Article

TMFGreenwave published an article 4:00 PM

Dendreon: Picking Through the Carnage

First-quarter results for the prostate cancer drug maker were even uglier than anticipated.

Article

TMFGreenwave published an article 3:00 PM

Deal Discussions Distract From Disappointing Obesity Drug Sales

Making sense of Vivus' first quarter results for investors.